Davidson Kempner Capital Management »

Rapport Therapeutics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Rapport Therapeutics shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $229k 10k 22.86